Author Correction: Cancer-associated Histone H3 N-terminal arginine mutations disrupt PRC2 activity and impair differentiation. - Nacev BA; Dabas Y; Paul MR; Pacheco C; Mitchener M; Perez Y; Fang Y; Soshnev AA; Barrows D; Carroll T; Socci ND; St Jean SC; et al. (Nature communications, 2024)